Jakob Holstiege1, Edeltraut Garbe. 1. Institute for Epidemiology and Prevention Research (BIPS), Achterstr. 30, 28359 Bremen, Germany.
Abstract
UNLABELLED: The aim of the study was to comprehensively describe antibiotic use among children and young adolescents in Germany. Outpatient prescriptions of systemic antibiotics to children (<15 years) were analysed using data from four German statutory health insurances for the years 2004 to 2006. Annual prevalence of antibiotic prescriptions was determined using the average number of insured children during the respective year as reference population. Annual antibiotic prescription rates were calculated per 1,000 person years. Both figures were stratified by age (0-4, 5-9 and 10-14 years) and sex. Frequent indications for prescribing were analysed. Annual prevalence of antibiotic prescriptions rose from 35.68 % [95 % confidence intervals (CI), 35.62-35.75] in 2004 to 37.79 % [95 % CI, 37.72-37.86] in 2006. Prescription rates slightly increased by 6.01 % from 668.54 [95 % CI, 667.34-669.72] antibiotic prescriptions per 1,000 person years in 2004 to 708.71 [95 % CI, 707.47-709.95] in 2006. In 2006, prescriptions of broad-spectrum penicillins (25.09 %), second-generation cephalosporins (18.11 %) and narrow-spectrum penicillins (16.45 %) were most frequent. The most common indication for antibiotic prescribing was tonsillitis followed by bronchitis, otitis media, acute upper respiratory infections and scarlet fever. CONCLUSION: In contrast to other northern European countries, paediatric prescription rates are high in Germany. This and the frequent prescribing of broad spectrum agents for the treatment of mostly viral self-limiting conditions indicate limited adherence to evidence-based practice guidelines in antibiotic prescribing in the German outpatient setting.
UNLABELLED: The aim of the study was to comprehensively describe antibiotic use among children and young adolescents in Germany. Outpatient prescriptions of systemic antibiotics to children (<15 years) were analysed using data from four German statutory health insurances for the years 2004 to 2006. Annual prevalence of antibiotic prescriptions was determined using the average number of insured children during the respective year as reference population. Annual antibiotic prescription rates were calculated per 1,000 person years. Both figures were stratified by age (0-4, 5-9 and 10-14 years) and sex. Frequent indications for prescribing were analysed. Annual prevalence of antibiotic prescriptions rose from 35.68 % [95 % confidence intervals (CI), 35.62-35.75] in 2004 to 37.79 % [95 % CI, 37.72-37.86] in 2006. Prescription rates slightly increased by 6.01 % from 668.54 [95 % CI, 667.34-669.72] antibiotic prescriptions per 1,000 person years in 2004 to 708.71 [95 % CI, 707.47-709.95] in 2006. In 2006, prescriptions of broad-spectrum penicillins (25.09 %), second-generation cephalosporins (18.11 %) and narrow-spectrum penicillins (16.45 %) were most frequent. The most common indication for antibiotic prescribing was tonsillitis followed by bronchitis, otitis media, acute upper respiratory infections and scarlet fever. CONCLUSION: In contrast to other northern European countries, paediatric prescription rates are high in Germany. This and the frequent prescribing of broad spectrum agents for the treatment of mostly viral self-limiting conditions indicate limited adherence to evidence-based practice guidelines in antibiotic prescribing in the German outpatient setting.
Authors: Hanneke B M Otters; Johannes C van der Wouden; Francois G Schellevis; Lisette W A van Suijlekom-Smit; Bart W Koes Journal: J Antimicrob Chemother Date: 2004-01-16 Impact factor: 5.790
Authors: Josta de Jong; Paul B van den Berg; Tjalling W de Vries; Lolkje T W de Jong-van den Berg Journal: Eur J Clin Pharmacol Date: 2008-06-18 Impact factor: 2.953
Authors: Jonathan A Finkelstein; Christopher Stille; James Nordin; Robert Davis; Marsha A Raebel; Douglas Roblin; Alan S Go; David Smith; Christine C Johnson; Kenneth Kleinman; K Arnold Chan; Richard Platt Journal: Pediatrics Date: 2003-09 Impact factor: 7.124
Authors: Elisabeth Engleder; Elisabeth Demmerer; Xueyan Wang; Clemens Honeder; Chengjing Zhu; Christian Studenik; Michael Wirth; Christoph Arnoldner; Franz Gabor Journal: Int J Pharm Date: 2015-02-24 Impact factor: 5.875
Authors: Sun Mi Shin; Ju-Young Shin; Mi Hee Kim; Shin Haeng Lee; Sohyun Choi; Byung-Joo Park Journal: J Korean Med Sci Date: 2015-04-15 Impact factor: 2.153
Authors: Jan-Willem H Dik; Bhanu Sinha; Alex W Friedrich; Jerome R Lo-Ten-Foe; Ron Hendrix; Robin Köck; Bert Bijker; Maarten J Postma; Michael H Freitag; Gerd Glaeske; Falk Hoffmann Journal: Antimicrob Resist Infect Control Date: 2016-04-18 Impact factor: 4.887